CV - Clinique de Cardiologie Montréal

Transcription

PETER BOGATY MD
CARDIOLOGUE & PROFESSEUR
CARDIOLOGIST & PROFESSOR
PUBLICATIONS
Adresse: Clinique de cardiologie de Montréal 3535 Queen Mary Suite 403 Montréal, Quebec Canada H3V 1H8 Tel: 514-‐731-‐6000 Fax: 514-‐731-‐2476 Revised March 15, 2013
Diplomas and Titles
M.D. University of Liège, Belgium, 1980
L.M.C.C. (Canadian Medical Licensing Examinations), 1983
Diplomate in Internal Medecine, American Board of Internal Medicine, 1986
C.S.P.Q. Médecine Interne (Quebec Internal Medicine Examinations), 1987
F.R.C.P.C. (Fellow, Royal College of Physicians, Canada), Internal Medecine, 1987
F.R.C.P.C. (Fellow, Royal College of Physicians, Canada) Cardiology, 1988
C.S.P.Q. Cardiology (Quebec-certified Cardiologist), 1989
Diplomate in Cardiovascular Medecine, American Board of Internal Medicine, 1989
Present Status
Member of the « Event Adjudication Committee » of the ORIGIN study, McMaster University,
Hamilton, Ontario 2011Member of the « Event Adjudication Committee » for the SCOUT Study (Sibutramine
Cardiovascular Outcomes Trial) 2003-2010
Medical Advisor of the Cardiac Evaluation Unit of the Quebec Health Technology Evaluation
Agency (Agence d'évaluation des technologies et des modes d'intervention en santé) (AETMIS)
2005 – on going
Member of the Advisory Committee for the National and International Classification of diseases
(ICD-10) for the Canadian Institute for Health Information 2007-2010
Member of the RUIS Committee in Cardiology 2006 - on going
“Professeur agrégé” (Associate Professor)
Département de médecine
Université Laval
Québec, Québec
Clinical Cardiologist (with privileges at the Institut universitaire de cardiologie et de pneumologie
de Québec and Sorel Hospital)
(Province of Quebec) 1991- on going
Member of the Editorial Board of the Canadian Journal of Cardiology 2002-2011
Member of the Canadian Cardiovascular Society
Member of the American Heart Association / American Stroke Clinical Cardiology Council
Peter Bogaty MD
Page 2 of 34
Actvities at the Institut national d’excellence en santé et en services
S
sociaux (INES S)
Peter Bogaty, MD
Medical and Scientific Advisor
PUBLICATIONS AND REPORTS:
External reviewer for 'Portrait de l'usage du dabigatran chez les personnes assurées par le
régime d'assurance médicaments' INESSS février 2013
Institut national de santé publique du Québec et l’Institut national d’excellence en santé et en
services sociaux (INESSS). Évaluation des soins et surveillance des maladies
cardiovasculaires :Pouvons-nous faire confiance aux données médico-administratives
hospitalières ? Claudia Blais, Laurie Lambert, Denis Hamel, Kevin Brown, Stéphane Rinfret,
Raymond Cartier, Maude Giguère, Céline Carroll, Christiane Beauchamp et Peter Bogaty.
Montréal, Qc : INESSS ; 2012. Rapport publié le 11 octobre 2012
Institut national d’excellence en santé et en services sociaux (INESSS). Evaluation of the
®
®
evidence on the HeartMate II and HeartWare ventricular assist devices for the treatment of
chronic end-stage heart failure. Georgeta Sas, Lucy J. Boothroyd, Jason R. Guertin, Laurie J.
Lambert, Jean E. Morin, Hadi Chakor et Peter Bogaty. ETMIS 2012; 8(15): 1-166.
Institut national d’excellence en santé et en services sociaux (INESSS). Implantation valvulaire aortique par cathéter. Évaluation des données probantes et synthèse des considérations
organisationnelles. Rédigé par Marco Spaziano, Lucy J. Boothroyd, Jason R. Guertin, Hadi
Chakor, Yongling Xiao, Laurie J. Lambert et Peter Bogaty. ETMIS 2012; 8(8): 1-84.
Lambert L, Brown K, Samek D, David K, Bogaty P. Le fichier Med-Echo du Québec est-il la
source de données appropropriées pour dénombrer les interventions coronarienne
percutanées (ICPP). Publié le 13 septembre 2011.
http://www.inesss.qc.ca/index.php?id=65&L=1&user_inesssdoc_pi1%5Bcode%5D=FICHE&us
er_inesssdoc_pi1%5Buid%5D=1313&user_inesssdoc_pi1%5BbackUrl%5D=index.php%253Fi
d%253D49%2526no_cache%253D1%2526L%253D1&cHash=9630954feaf9c44093bf4df3b93
947b8
Boothroyd LJ, Lambert L, Bogaty P, Evidence meets context: a case study in an evaluation of
care for acute myocardial infarction. Part 1 and 2. ID : 11778/11779. Présentation HTAi 2008,
AETMIS/RQCT 2008. http://www.aetmis.gouv.qc.ca/site/en_equipe_cardiologie.phtml
Bogaty P, Boothroyd LJ, Lambert L, Lance JM, Paquette D. Organizational and Economic
Issues in the Management of Patients with Acute ST-segment Elevation Myocardial Infarction
(STEMI): Summary. AETMIS 2008.
http://www.aetmis.gouv.qc.ca/site/en_publications_2008.phtml
Bilodeau C, Giguère M, Lambert L, Bogaty P. Implementation of a province-wide fi eld
evaluation of the management of acute myocardial infarction with ST segment elevation in
Québec hospitals. ID : 11831/11832. Présentation HTAi 2008, AETMIS/RQCT 2008.
http://www.aetmis.gouv.qc.ca/site/en_equipe_cardiologie.phtml
Peter Bogaty MD
Page 3 of 34
Lambert L, Bogaty P, Bilodeau C, Giguère M, Boothroyd LJ, Morin J. Management of acute
myocardial infarction with ST-segment elevation (STEMI) in the Québec context: Preliminary
results of a field evaluation (ETIAMEST) and their usefulness for decision-makers. Part 1 and
2. ID : 11780/11781. Présentation HTAi 2008, AETMIS/RQCT 2008.
http://www.aetmis.gouv.qc.ca/site/en_equipe_cardiologie.phtml
Lambert L, Brophy JM, Boothroyd LJ, Bogaty P. The performance of percutaneous coronary
interventions in hospitals without on-site cardiac surgery : Review of guidelines and analysis of
Quebec data from 1994 to 2004. ID : 11833/11834. Présentation HTAi 2008,
AETMIS/RQCT2008. http://www.aetmis.gouv.qc.ca/site/en_equipe_cardiologie.phtml
Lambert L, Brophy JM, Bogaty P. Rapport sur la revascularisation coronarienne par pontage
et par angioplastie chez les personnes âgées. AETMIS/MSSS/RQCT 2005-2007.
Lambert L, Erickson L, Brophy JM, Bogaty P. Rapport sur l’ouverture de salles
d’hémodynamie sans support chirurgical sur place: Partie II. Revue de la littérature.
AETMIS/MSSS 2006-2007.
Lambert L, Bogaty P. Rapport sur l’ouverture de salles d’hémodynamie sans support
chirurgical sur place: Partie II. Évaluation des résultats au Québec 1999-2004 des centres
avec versus sans rapport chirurgical sur place . AETMIS/MSSS 2006-2007.
Perron S, Huynh T. (Bogaty P, consultant) Rapport sur le traitement de l’infarctus avec
élévation du segment ST : Partie I. Analyse des registres et méta-analyses. AETMIS/MSSS
2006-2007.
Lambert L, Boothroyd L, Paquette D, Bogaty P. Rapport sur le traitement de l’infarctus avec
élévation du segment ST : Partie II. Dimension contextuelle. AETMIS/MSSS 2006-2007
L. Lambert, JM Moutquin, S. Poliquin, JE Morin, B DeVarennes, L Perrault, P Voisine, LM
Stevens, JF Morin, P Pagé, J Teijeira, J Mathieu. Rapport préliminaire d'évaluation des
résultats des PAC au Québec 2002-2004 et 2005-2008
Peter Bogaty MD
Page 4 of 34
Previous Posts
Senior Clinical Research Scholar of the FRSQ (Fonds de Recherche en Santé du Québec)
2002-2004
Director of the Quebec Heart Institute, 1999-2003
Chief of the Department of Cardiology. Laval Hospital, 1999-2003
Director, Coronary Care Unit
Quebec Heart Institute / Laval Hospital 1991-2003
Member of the Research Committee at the Quebec Heart Institute 1998-2005
Staff Cardiologist, Maisonneuve-Rosemont Hospital, Montreal, April-August, 1991
Previous Status
Junior Clinical Research Scholar "Fonds de Recherche en Santé du Québec" (FRSQ) 1992-96
Cardiology Research Fellow, Cardiovascular Research Unit (Professor Attilio Maseri)
Royal Postgraduate Medical School, Hammersmith Hospital, London, UK, 1989-91
Residency in Cardiology, Quebec Heart Institute, Laval Hospital, Laval University, Quebec, 198788
Residency in Cardiology, Montreal Heart Institute, University of Montreal, 1986-87
Residency in Internal Medicine, Laval University, Quebec, 1984-86
Rotating Internship, Laval University, Quebec, 1982-83
Residency in Internal Medicine, Joseph Wauters Hospital, (Liège University), Waremme,
Belgium, 1980-82
Peter Bogaty MD
Page 5 of 34
Committees and Memberships
Member of the Advisory Committee for the National and International Classification of diseases
(ICD-10) for the Canadian Institute for Health Information 2007Member of the RUIS Committee in Cardiology 2006President of the Scientific Committee of the Quebec Tertiary Cardiology Network 2004-2007
Member of the Executive Committee of the FRSQ-sponsored Cardiovascular Network 2004-2006
President of the Acute Coronary Care Working Group of the Quebec FRSQ-Sponsored
Cardiovascular Network 1998-2004
Member of the Canadian Working Group of the Canadian Vascular Society for the Adaptation to
Canada of the The American College of Cardiology (ACC) / American Heart Association (AHA)
Guidelines for the Management of Patients with ST Segment Elevation Myocardial Infarction
2004
External Peer Reviewer for the The American College of Cardiology (ACC) / American Heart
Association (AHA) Guidelines for the Management of Patients with ST Segment Elevation
Myocardial Infarction 2003
Member of the evaluating committee for the ‘Fonds de la santé du Québec’ (FRSQ) research
scholarship program 2004
Member of the Editorial Board of the Canadian Journal of Cardiology 2002Member of the Event Adjudication Committee for the SCOUT Study (Sibutramine Cardiovascular
Outcomes Trial) 2003Member of the Canadian Cardiovascular Society
Member of the American Heart Association / American Stroke Clinical Cardiology Council
Member of the American Heart Association / American Stroke Association Arteriosclerosis,
Thrombosis & Vascular Biology Council
Member of the Quebec Heart Institute Research Committee, 1998Member of the Executive Committee of the Quebec Tertiary Cardiology Network 2000-2003
Member of the Advisory Committee for AETMIS (Agence d’Évaluation des Technologies et des
Modes d’Intervention en Santé) on Positron Emission Tomography 2001-2002
Member of the CCS Consensus Conference 2002: Management of Heart Disease in the Elderly
Patient; Management of Acute Coronary Syndromes in the Elderly 2002
Member of the Primary Panel of the Canadian Cardiovascular Society Consensus on Angina
Pectoris (1996-97) (Can J Cardiol 1998;14 (Suppl C):1C-24C)
Peter Bogaty MD
Page 6 of 34
Member of the Cardiopulmonary and Critical Care Council of the American Heart Association
1995-2000
Member of the ad hoc Positron Emission Tomography Committee, Laval Hospital, 1997-2003
President of the Resuscitation Committee, Laval Hospital, 1994-2003
Member of the Nominating Committe for the Directorship of the Quebec Heart Institute, 19971998
Member of the Committee of Admission Standards, Laval Hospital, 1995-1997
President of the CMDP ad hoc Committe of Laval Hospital for the Evaluation of Treatment of
Morbid Obesity by Biliopancreatic Derivation 1995-96
Peter Bogaty MD
Page 7 of 34
Teaching Activities
Animateur du cours EPM-7004 : Recherche appliquée au domaine de la santé. Université Laval
2009 – en cours/on going
Member of the Examination Committee for the Master thesis of Olivia Drescher, Laval University,
1999
Professeur contribuant au cours en épidémiologie et santé publique du 1er cycle EPM-62616-A
et SAC-67322-A Recherche appliquée au domaine de la santé. 2007- 2009
Faculty of Medicine; Laval University, course on Ischemic Heart Disease to first-year students
(12h/year) 1995-2007
Workshop on cardiovascular disease, Laval University, [Epidemiology of major healthcare
problems (EPM-66599)], Maladies circulatoires - Maladies ischémiques du cœur, October 11,
2006
Member of the evaluating committee for the thesis of Julie Methot, December 16, 2005; Maladie
coronarienne chez la femme: influence des hormones et du polymorphisme insertion/délétion du
gène de l’enzyme de conversion de l’angiotensine
Supervision of Naji Wakil, medical student attending Laval University – research project of serial
angiograms in the study RISCA 2005Workshop on cardiovascular disease, Laval University, [Epidemiology of major healthcare
problems (EPM-66599)], October 12, 2005
Director of master of science training and thesis of Ms Audrey Marcoux 2004-5
Director of PhD student Martin Noël (‘Investigation sur le préconditionnement et l’entraînement du
myocarde ischémique’) 2003-7
Evaluator of the MSc thesis of Marie-Pierre Dumas, July 2004 (Influence of cardiovascular
medication on the results of the dobutamine stress echocardiogram in normal subjects)
Co-director of Dr Phung Nguyen Xuan’s master degree, Laval University, 1996-1999
Co-supervisor of Dr Paola Muré, research program, 1993-1994
Member of the Predoctoral Examination Committee of Claudia Blais (‘Étude dynamique de la
sténose aortique’) July 2001
Member of the Examination Committee for the doctoral thesis of Denis Boucher, Laval University,
1999
Course on Acute and Chronic Coronary Heart Disease (10h/year) to residents and fellows in
cardiology,1995-2003
Teaching Rounds in the Coronary Care Unit (residents in internal medicine and cardiology), Laval
Hospital 1991-
Peter Bogaty MD
Page 8 of 34
Invited Speaker Activities
Invited speaker at the development day for the AGISQ (Quebec archivistes), Rôle des
gestionnaires de l’information de la santé du Québec dans l’excellence clinique: Expérience
pratique de l’unité d’évaluation en cardiologie tertiaire de l’Institut national d’excellence en santé
et en services sociaux, Hilton Hotel, Montreal, May 10, 2012
Invited speaker at the McGill Centre for Continuing Education. Atrial Fibrillation. Jewish General
Hospital, Montreal, May 12, 2011
Invited professor, speaker at Cardiology Programm of the university of Montreal ST Elevation
myocardial: thrombolysis. Hôpital du Sacré-Coeur, Montreal April 12, 2011
Invited speaker, importance of common data definitions at the Institut national d’excellence en
santé et en services sociaux (INESSS). The Canadian Cardiovascular Data Definitions and
Quality Indicators Project, Toronto 11 mars 2011
Invited speaker at the Table des directeurs médicaux régionaux des services préhospitaliers
d'urgence. Résultats des analyses concernant la prise en charge des infarctus du myocarde avec
élévation du segment STVille LaSalle 16 février 2011
A systematic province-wide field evaluation STEMI care. Colloque du département
d'épidémiologie de l'université McGill. Montréal 27 janvier 2011
Invited expert at the meeting of Urgences Santé. ETIAMEST II : les aspects préhospitaliers.
Montréal 10 nov 2010
Invited expert at the CCORT Annual National Meeting. Toronto May 3-4 2010
Chair scientific session at the Vascular Protection Forum 2010. Toronto, June 4-5 2010
Invited speaker at the Quebec Society of Vascular Sciences. Continuing Health Education
Program, afternoon symposium Lipids 2010. The usefulness of high sensitivity C-Reactive
th
Protein in the evaluation of CV risk. Montreal, January 15 , 2010.
Invited speaker at McGill University Health Centre, division of Clinical Epidemiology Seminar
Series. Field Evaluation of Myocardial Infarction with ST-Elevation in Quebec. Montreal, October
29, 2009
Bogaty P, Lambert L, Bilodeau C. RQCT, table de concertation annuelle. Trois-Rivières, June 7,
2009.
Bogaty Peter (con). Debate at the Vascular Protection Forum: CRP should be part of the risk
assessment of our patients. Toronto, May 30, 2009.
Lambert L, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude
terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), videoconference,
Montréal, 19-Mar-09, Abitibi
terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Beauce, 26-Feb-09,
Chaudière-Appalaches
terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Hull, 3-Feb-09,
Outaouais Agency (Hull)
Peter Bogaty MD
Page 9 of 34
Invited speaker at St-Michael’s Cardiac Research Rounds. « Atherosclerosis, Inflammation and
Biomarkers: What is the Fit? » Toronto, Ontario, January 26, 2009
Invited speaker at St-Michael’s Cardiac Grand Rounds. « To CRP or not to CRP ». Toronto,
Ontario, January 26, 2009
terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Montréal, 22-Jan-09,
Montréal region
terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), visioconference,
Montréal,15-Jan-09, Lac St-Jean
terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Montréal, 15-Jan-09:
Presentation at the Montreal Heart Institute
Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study
(ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), 16Dec-08, Laval
(ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST),
Québec, 15-Dec-08, Québec region
(ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), TroisRivières, 9-Dec-08, Mauricie/Quebec centre region
videoconference, Montréal, 28-Nov-08, Bas St-Laurent region
Longueuil, 20-Nov-08, Montérégie region
Montréal, 3-Nov-08: Tertiary Cardiology and RUIS
Montréal,10-Oct-08: Presentation to the DSPs
Lambert L, Giguère M, Bilodeau C, Bogaty P . RResults STEMI Field Evalutation Study
Québec, 9-Oct-08: Presentation at DRAMU (Directeur Régional des Affaires Médicales et
Universitaires).
Drummondville, 6-Oct-08: Presentation at Réseau Québecois de cardiologie tertiaire (RQCT).
Peter Bogaty MD
Page 10 of 34
Montréal, 2-Oct-08; Presentation at the RUIS
Québec,10-Sep-08: Presentation at Ministère de la Santé et Services Sociaux (MSSS).
Lambert L, Giguère M, Bilodeau C, Bogaty P. HTAi, Montréal, Jul-08, HTAi convention
Lambert L, Giguère M, Bilodeau C, Bogaty P. Preliminary Results STEMI Field Evalutation Study
Québec, 5-Jun-08: Presentation at Ministère de la Santé et Services Sociaux (MSSS).
Presentation of a Workshop in Coronary Artery Disease Management at the Vascular Protection
Forum, Toronto, May 31, 2008.
Invited speaker at the Scientific Committee of the Quebec Tertiary Cardiology Network ( RQCT):
STEMI Field Evalutation (ETIAMEST). Montréal, September 25, 2007
Coronary angioplasty in hospitals with and without cardiac surgery. Montréal, September 25,
2007
Coronary revascularisation in aged patients in Québec. Montréal, November 20, 2007
Invited speaker at the Agence d'évaluation des technologies et des modes d'intervention en
santé. AETMIS. Coronary angioplasty in hospitals with and without cardiac surgery.
Presentation to hospital directors (directeurs des services professionnels), Montréal, September,
2007
Participation at a meeting for a project of collaboration between l'INSPQ (Institut national de
santé publique au Québec)e t l'AETMIS for the validation of Quebec hospital medicoadministrative databases to establish monitoring and evaluation in cardiology. Agence
d'évaluations des technologies et des modes d'intervention en santé. AETMIS, Montreal, July 27,
2007
Participation at the CIHR cardiac waiting times meeting,Ottawa, Ontario, July9, 2007
RQCT annual meeting presentation of AETMIS Cardiac Evaluation Unit activities. Montréal,19
juin 2007
Participation at the « Vascular Protection Forum » - - Prevention of vascular, renal, and
metabolic abnormalities: Implications of the renin angiotensin aldosterone system. Toronto,
Ontario, June 9, 2007
Invited speaker at the medicine department: 'Le traitement de l'infarctus du myocarde avec
élévation du segment ST'. Ste-Agathe des Monts Hospital, April 17, 2007
Invited speaker at the Epidemiology department: In quest of the holy grail: Prediction in coronary
artery disease. Royal Victoria Hospital, McGill University Health Center, March 8, 2007
Invited speaker at the medicine department: 'Le traitement de l'infarctus avec élévation du
segment ST relève-t-il idéalement de la cardiologie tertiaire? Drummondville, January 16, 2007
Invited speaker at the emergency and medicine department : l’infarctus du myocarde avec
élévation du segment ST : Est-ce que le traitement idéal relève de la cardiologie tertiaire? HôtelDieu de Sorel, Boucherville, November 28, 2006
Peter Bogaty MD
Page 11 of 34
Invited speaker at the emergency and medicine department of Hôtel-Dieu d’Arthabaska :
l’infarctus du myocarde avec élévation du segment ST : Est-ce que le traitement idéal relève de
la cardiologie tertiaire? Hôtel-Dieu d’Arthabaska, Victoriaville, October 16, 2006
Invited speaker at the Consultation Round Table of the RQCT (Réseau québécois de cardiologie
tertiaire): Résultats de l’étude sur la revascularisation chez les personnes âgées de plus de 80
ans. June 20, 2006
tertiaire): Avis sur l’efficacité et l’efficience de la thrombolyse et de l’angioplastie primaire dans le
traitement de l’infarctus aigu du myocarde avec élévation du Segment ST. June 20, 2006
tertiaire): Évaluation-terrain du traitement de l’infarctus du myocarde avec élévation du Segment
ST. June 20, 2006
Invited speaker at the cardiology department of McGill University Health Centre; Montreal
General Hospital: Acute ST-Elevation Myocardial Infarction (STEMI): Is PCI for all ideal? May 10,
2006
Invited speaker at the 2005 annual meeting and Symposium of the Canadian Association of
Cardiac : Issues in Cardiac Rehabilitation & Prevention; Training above the ischemic threshold / A
World to Know Better. CCS Montreal, October 23, 2005
Invited speaker to the symposium Advances in cardiology : CRP-Targeted Therapy Offers a
Marginal Advantage over Aggressive LDL Reduction. CCS Montreal, October 22, 2005
Discussant at a Roundtable at the 14th Interventional Cardiology Symposium on thrombolysis
and PCI, Montreal (Montreal Heart Institute) June 18, 2005.
Invited Speaker to the 14th Interventional Cardiology Symposium : Acute Myocardial Infarction
Reperfusion Strategies (STEMI Guidelines) : A case for Thrombolysis, Montreal (Montreal Heart
Institute) June 18, 2005.
Invited Speaker to the 10th Annual Atlantic Canada Cardiovascuar Conference : Evidence,
Guidelines and Common Sense, Dalhousie University Faculty of Medicine Halifax April 15-16,
2005
Invited Speaker to the 10th Annual Atlantic Canada Cardiovascuar Conference : Acute
Management : Direct Intervention of Thrombolysis ; Management of Acute STEMI in 2005,
Dalhousie University Faculty of Medicine Halifax April 15-16, 2005
Invited Speaker at a meeting organized by the emergency physicians of the Centre hospitalier du
Haut-Richelieu on the contemporary treatment of acute myocardial infarction March 31, 2005
Peter Bogaty MD
Page 12 of 34
Invited Speaker at the Grand Rounds of the department of medicine of Charles LeMoyne
Hospital : Treatment of ST elevation Myocardial Infarction; what is the evidence for the best
treatment. Montreal March 24, 2005
Presenter at the Eastern Regional Atorvastatin Consultancy Committee Meeting (PROVE-IT;
Opposing Viewpoint) Montreal February 9, 2005
Invited Speaker at JANUS VIII: Optimizing Current Pharmacotherapy in ST Elevation Myocardial
Infarction, Whistler January 21, 2005
Invited Speaker for emergency and cardiology department of Hôtel-Dieu de Québec Hospital; Le
traitement de l’infarctus aigu du myocarde en 2005 suite aux recommandations de
l’AHA/ACC/CCS, Quebec, January 18, 2005
Invited Speaker for the internists at Centre Hospitalier Régional du Grand-Portage: Le traitement
de l’infarctus aigu du myocarde en 2005 suite aux recommandations de l’AHA/ACC/CCS,
Rivière-du-Loup, December 15, 2004
Invited Speaker at the annual meeting of the cardiology department, Centre Hospitalier de
l’Université de Montréal (CHUM); Le traitement de l’infarctus aigu du myocarde en 2005 suite
aux recommandations de l’AHA/ACC/CCS, Un débat scientifique. Montreal, Vogue Hotel,
November 20, 2004
Invited Speaker for Canadian Working Group of the Canadian Cardiovascular Society: Choosing
Reperfusion Therapy / Convalescent Evaluation, Calgary October 25, 2004
Invited Speaker at the emergency and cardiology department, Saint-François d’Assise Hospital;
Infarctus du myocarde avec élévation ST: thrombolyse et angioplastie primaire, Quebec, October
21, 2004
Invited Speaker at the 6th National Atherosclerosis Forum; Fluctuating Inflammatory Markers in
Patients With Stable Ischemic Heart Disease, Toronto, September 2004
Invited Speaker at the Canadian Cardiovascular Society, Meet-the-Expert-session, Calgary
Workshop Proposal: Biomarkers in the Management of Acute Coronary Syndromes, October 25,
2004
Invited Speaker at the Canadian Cardiovascular Society, Meet-the-Expert-session, Calgary
Workshop: Introducing the Canadian Working Group Adaptation of the AHA/ACC 2005
Guidelines on the Management of ST Elevation Myocardial Infarction, October 25, 2004
Invited speaker at JANUS VII, Contemporary Cardiovascular Medicine with a View to the Future,
Aging in the Cardiovascular System: Physiologic Change or Pathophysiologic Inevitability?
Jamaîca, January 18, 2004.
Invited speaker at the Ground Rounds, Montreal Heart Institute: Inflammation et maladie
coronarienne : promesse et problématique, October 2, 2003
Invited speaker at the 5th annual convention of the « National Atherosclerosis Forum » Halifax,
September 19-21 2003
Invited speaker at Laval University for the presentation of project for the creation of a center on
the prevention of cardiovascular disease , Université Laval, May 5, 2003
animation of a ‘Brunch’ for the Quebec Heart Insitute at the PPMC of Laval Hospital, december
1, 2002 (Theme: Prevention in cardiovascular heart disease)
Peter Bogaty MD
Page 13 of 34
Invited speaker at a scientific conference at l’INSERM in Paris, for the FRSQ : Maladie
coronarienne et inflammation, November 6, 2002
Organisation and animation of the 'Retraite de l’Institut de cardiologie de Québec', Lac Delage
Manor, Quebec, November 2, 2002
President of a session at the 29th International Convention of Electrocardiology on cardiac
monitoring and Acute Coronary Heart Syndrome ,Montreal, July 4, 2002
Presentation au Colloque annuel de formation médicale de l'Association des médecins
omnipraticiens de Québec, 26 avril, 2002 à Québec sur 'Les nouveaux facteurs de risque de la
maladie coronarienne"
Invited speaker of a session for the cardiologist association of Quebec regional scientific
conference : "Les nouveaux facteurs de risque de la maladie coronarienne" Atelier scientifique
régional, Mont Sainte-Anne, January 27, 2002;
Protagoniste à un débat à la Société canadienne de cardiologie, congrès 2001 à Halifax (22
octobre) au Symposium Satellite: La prise en charge des patients présentant un risque accru
d'événements cardiovasculaires: les véritables débats. Sujet: Devrions-nous être plus sélectifs
lorsque nous prescrivons des "pilules" éprouvées pour la prévention secondaire?
Président d’un colloque ('La prescription d'exercice: considérations spéciales') au 2e Symposium
international de Québec sur la réadaptation cardio-respiratoire 6-8 juin, 2001
Presentation à l’Atelier régional scientifique de l’Association des cardiologues du Québec sur
« Les inhibiteurs des récepteurs IIb/IIIa plaquettaires », le 20 septembre 2000
Invited speaker National Atherosclerosis Forum: Results of the Can-ADA substudy on endothelial
function. Montréal ) 22-24 septembre, 2000
Invited speaker at the symposium "Acute Coronary Syndromes: Searching for Innovative
Solutions" (HealthCare Communications - Schering Canada Inc.), Hockley Valley Resort
(Ontario), May 12-14, 2000
Invited speaker at the Grand Rounds, Quebec Heart Institute: A case of Acute Coronary
Syndrome. April 27, 2000
Presentation au professeur A. Murad, prix Nobel de la médecine, à l’Hôpital Laval 23 avril 2000.
Inflammation et maladie coronarienne
Présentation aux médecins de l'urgence de l'Hôpital Laval sur la thrombolyse dans l'infarctus
aigu, le 31 mars, 2000
Conférencier pour l’étude Can-ADA et la sous-étude sur la fonction endothéliale lors du Canadian
Atorvastatin Research Roundtable (CARR), New York, 11-13 février, 2000
Grand Rounds de l’Institut de cardiologie de Québec 22 septembre 1999, Un cas d’angine postinfarctus
Présentation à la journée de la recherche, Faculté de médecine, Université Laval, 25 mai, 1999,
L'adénosine est-elle le médiateur impliqué dans l'atténuation de l'ischémie myocardique observée
après un exercice de réchauffement?
Peter Bogaty MD
Page 14 of 34
Présentation sur ‘Le retour au travail post-infarctus’ le 25 avril, 1998 à l’Université Laval aux
omnipraticiens dans le cadre du 7ième Colloque annuel de médecine du travail et de
l’environnement du CLSC Haute-Ville
Présentation au personnel du centre de recherche de l’hôpital Laval sur l’interprétation de l’ECG,
7 décembre 1997
Présentation à St John’s, Terre Neuve au Memorial University, Grand Rounds de médecine,
L’angine instable: nouvelles données sur la pathogénèse et la thérapeutique, 5 décembre 1997
Présentation à la réunion de recherche en cardiologie 22 octobre, 1997, Nouvelles données: une
dichotomie entre la maladie coronarienne aigue et la maladie coronarienne chronique
Président d’une séance à la 4ième Conférence internationale de cardiologie préventive, Montréal,
30 juin, 1997, L’approche clinique du patient avec cardiopathie ischémique ou accident vasculaire
cérébral
Conférence conjointe de médecine de l’hôpital Laval, Nouveautés en réanimation cardiorespiratoires: nouveaux algorithmes d’intervention, 14 janvier, 1997
Présentation au personnel du centre de recherche a l’hôpital Laval, La cardiopathie ischémique
les 19 et 26 novembre, 1996
Présentation au congrès de l’Association québécoise des infirmières et infirmiers en recherche
clinique. Le rôle des plaquettes et de la coagulation dans les syndromes coronariens aigus, 18
octobre 1996
Accueil du Dr Lance Gould et du Dr Fréderic Sax pour présentations à la Société de cardiologie
de Québec et à la réunion de recherche de l’Institut de cardiologie de Québec, 23-24 septembre
et 30 septembre-1er octobre, 1996
Invited speadker at the Grand Rounds of the Jewish General Hospital, Montreal, April 29, 1996.
Unstable Angina: Update and Overview”
Invited speaker at the research ground rounds of the Quebec Heart Institute, L’unité coronarienne
informatisée, March 20, 1996
President of a symposium, Le continuum de l’angine: nouvelles perspectives sur les mécanismes
sous-jacents, Quebec (Château Frontenac), November 24-26, 1995
Invited speaker for the family physicians: La maladie coronarienne: concepts et prévention.
Beaupré, Quebec June 13,1995
Invited speaker for the "clinician point of view" at, Méga-études symposium, recommandations
provinciales et pharmaco-économie: leur impact sur la pratique médicale at the Ritz Carlton,
Montreal, June 9,1995
Invited speaker at the Quebec cardiologist association convention de l'Association, debate
protagonist-antagonist, Le meilleur traitement de l'angine instable: pharmacologique vs
mécanique, Chicoutimi. Quebec June 1, 1995
Invited speaker at a panel-discussion, Angina Continuum Roundtable Meeting (Healthlink
Communications) at the American College of Cardiology session meeting. New-Orleans, March
18, 1995
Invited speaker at the Royal Victoria Hospital: Cardiology Research Rounds, Stratification de
Peter Bogaty MD
Page 15 of 34
risque post syndrome coronarien aigu: nouvelles perspectives et proposition pour une étude
clinique. Montreal, January 23, 1995
Invited speaker at the cardiology department of Hôtel Dieu de Lévis , Quebec: presentation of the
DOMASCA Study. December 10. 1994
Invited speaker at the medicine interdepartmental meeting, Hôpital St-François d’Assise: Les
béta-bloqueurs post-infarctus. Quebec April 3, 1994
Invited speaker at the emergency department of Laval Hospital: Introduction to the GUSTO II
Study. March 25, 1994
Invited speaker at the cardiology department of Hôpital de l’Enfant-Jésus, Quebec: presentation
of the DOMASCA Study. March 9,1994
Invited speaker at the Grand Rounds’, Hôpital St-François d’Assise, Quebec on thrombolysis.
March 2, 1994
Peter Bogaty MD
Page 16 of 34
RESEARCH GRANTS
Development of a Genetic Risk Score to Predict Adverse Outcomes After an Acute Coronary
Syndrome. Principal Investigator(s): THANASSOULIS, George Co-Investigators: BOGATY,
Peter; BROPHY, James M; ENGERT, James C; PILOTE, Louise. - Operating Grant
Competition(Year/Month): 2011/09 Assigned Peer Review Committee: CID Clinical Investigation
- D Primary Institute: Population and Public Health Primary Theme:
Social/Cultural/Environmental/Population Health Term (Yrs/Mths): Sept 15, 2011 for 2 yrs 0 mth
$161670
AETMIS/Santé et Services Sociaux Québec, Subvention, Obtenu , Plan de 5 ans –evaluation en
cardiologie, Peter Bogaty MD Laurie Lambert PhD Celine Carroll-Bilodeau Maud Giguère,
Chercheur principal , 09-2008-09-2013, $300 000
Ministère de la santé et des services sociaux, Subvention , Obtenu , Évaluation-terrain de
l'infarctus du myocarde avec élévation ST -2 (ETIAMEST-2), Peter Bogaty, Laurie Lambert, Jean
Morin, Celine Carroll-Bilodeau, Chercheur principal , 09-2009-08-2014, $330 000
Investigation of Fluctuations in Inflammatory Markers in Stable Subjects Across the Clinical
Spectrum of Ischemic Heart Disease Canadian – Operating Grant from the Canadian Institutes of
Health Research (CIHR 2004). Principal applicant: Peter Bogaty; co-applicants: James Brophy,
Janos Filep, Lawrence Joseph, Gilles R Dagenais ($240 342) 2006-2010.
Effect Modfication of Gene-Mediated Susceptibility to Myocardial Infarction by Sex and Other
Conventional Coronary Risk Factors – Principales initiatives stratégiques – Canadian Institutes of
Health Research (CIHR). Principal Appliquant: Louise Pilote, Igor Karp; co-appliquants: Peter
Bogaty, James Brophy, James Engert ($100 000) 2008-2010
Identification of Genetic Polymorphisms as a Predictor of Myocardial Infarction upon use of
selective Cox-2 inhibitors. Appliquant principal: Dr JM Brophy, co-appliquant: C St. Germain, J
Engert , P Bogaty. MUHC Pilot Project Competition.$20,000 November 2006
Toward Canadian Benchmarks for Health Services Wait times – Evidence, Application and
Research Priorities II : Research Syntheses – Canadian Institutes of Health Research Strategic
RFA (CIHR March 2006); Principal applicant: Tanya Armour; co-applicants: Dr Peter Bogaty, Dr
George Well, Dr Ross Davies, Dr Jack Tu, Dr David Moher, Gregory Hirsch, Dr Blair O'Neill, Dr
Kevin Glasgow, Dr Robert Gow ($92 974) 2006
Evaluation of a Novel Multi-Marker Approach (CRP and P-Selectin) to Risk Stratification in Acute
Coronary Syndromes – Grant-in-aid to the Heart & Stroke Foundation of Canada ; Principal
applicant: Peter Bogaty; co-applicant: Dr James Brophy, ($39 000) 2005-2008
Unrestrictive Grant Request to Pfizer Canada Independent Cardiovascular Research: Evaluation
of a Novel Multi-Marker Approach (CRP and P-Selectin) to Risk Stratification in Acute Coronary
Syndromes ($85 453) November 2005
Heart and Stroke Foundation Research Funding: Evaluation of Markers of Inflammation and Pselectin in Acute Coronary Syndromes. ($31 000) 2002-2004
Fonds de Recherche en Santé du Québec, Réseau cardio-vasculaire : Evaluation of Markers of
Inflammation and P-selectin in Acute Coronary Syndromes. ($78 000) 2003
Fonds de Recherche en Santé du Québec, Réseau cardio-vasculaire: Investigation of C-Reactive
Protein and Tumor Necrosis Factor Alpha as Markers of Persistent / Recurrent Instability in the
Acute Coronary Syndromes (Étude RISCA). ($100 000) 2002
Peter Bogaty MD
Page 17 of 34
Canada Foundation for Innovation (CFI), (‘Réseau québécois d’études multicentriques en
cardiologie’) (Multicenter project; ICM-U de M, Quebec Heart Institute/Laval University, McGillCardiology, CHUS-Cardiology. ($2 795 930) 2002
RISCA Study (Recurrence and Inflammation in Acute Coronary Syndromes) unrestricted grant
Hoffman-La Roche Ltd, Canada. ($34 364) 2000
Can-ADA Substudy (Effect of Atorvastatin on Endothelial Function and on Exercise Ischemic
Threshold) unrestricted grant Pfizer Canada Inc. ($24 380) 2001-2002
Principal Investigator for The Canadian Atorvastatin Trial (Can-ADA) Parke-Davis Canada.
($50 000) 1998-2001
RISCA Study (Recurrence and Inflammation in Acute Coronary Syndromes) unrestricted grant
Merck Frosst Canada Inc. ($18 000) Sept 2000
Can-ADA Substudy (Effect of Atorvastatin on Endothelial Function and on Exercise Ischemic
Threshold) unrestricted grant; Parke-Davis Canada. ($7 500) 1998-2000
Laval Hospital Foundation Pilot Study, (Short Hospital Stay in Low-Risk Myocardial Infarction)
($10 000) 1997
Peter Bogaty MD
Page 18 of 34
PUBLICATIONS IN MEDICAL JOURNALS
1.
Bogaty P, Dagenais GR, Joseph L, Boyer L, Leblanc A, Bélisle P, Brophy JM. Time
Variability of C-Reactive Protein: Implications for Clinical Risk Stratification. In press PLoS
ONE 2013
2.
Dagenais GR, Lu J, Faxon DP, Bogaty P, Adler D, Fuentes F, Escobedo J, Krisnaswami A,
Slater J, Frye RL. Prognostic Impact of the Presence and Absence of Angina on Mortality
and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Stable Coronary Artery
Disease Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes
(BARI 2D) trial. J Am Coll Cardiol 2013 Feb 19;61:702-1.
3.
Boothroyd LJ, Segal E, Bogaty P, Nasmith J, Eisenberg MJ, Boivin JF, Vadeboncœur A,
Champlain FD. Information on Myocardial Ischemia and Arrhythmias Added by Prehospital
Electrocardiograms. Prehosp Emerg Care 2012;17:187-192.
4.
Boothroyd LJ, Spaziano M, Guertin JR, Lambert LJ, Rodés-Cabau J, Noiseux N, Nguyen M,
Dumont E, Carrier M, de Varennes B, Ibrahim R, Martucci G, Xiao Y, Morin JE, Bogaty P.
Transcatheter Aortic Valve Implantation: Recommendations for Practice Based on a
Multidisciplinary Review including Cost-effectiveness, Ethical and Organizational Issues.
Can J Cardiol 2012 Dec 3. doi:pii: S0828-282X(12)01304-9. 10.1016/j.cjca.2012.09.002.
[Epub ahead of print]
5.
Lambert L, Blais C, Hamel D, Brown K, Rinfret S, Cartier M, Giguère M, Caroll C,
Beauchamp Christiane, Bogaty P. Evaluation of care and surveillance of cardiovascular
disease: Can we trust medico-administrative hospital data? Can J Cardiol 2012;28:162-8.
[Epub ahead of print]
6.
Bogaty P, Filion K, Brophy JM. Routine Invasive Management After Fibrinolysis in Patients
with ST-Elevation Myocardial Infarction: A Critical Review. BMC Cardiovasc Disord.
2011;11:34.
7.
Hamelin BA, Zakrzewski-Jakubiak M, Robitaille MN, Bogaty P, Labbé L, Turgeon J.
Increased risk of myocardial infarction associated with angiotensin-converting enzyme gene
polymorphism is age dependent. J Clin Pharmacol 2011; 51:1286-92.
8.
St Germain CG, Bogaty P, Boyer L, Hanley J, Engert JC, Brophy JM. Genetic
polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs. Am J
Cardiol 2010;105:1740-5.
9.
Lambert L, Brown K, Segal E, Brophy J, Rodes-Cabau J, Bogaty P. Association between
timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction.
JAMA 2010;303:2148-55.
10. Cardinal H, Brophy JM, Bogaty P, Joseph L, Hébert MJ, Boyer L, Madore F. Usefulness of
Fas levels for improving diagnostic accuracy and prognosis for acute coronary syndromes.
Am J Cardiol 2010; 105:797-803.
11. Noël M, Jobin J, Marcoux A, Poirier P, Dagenais GR, Bogaty P. Comparison of Myocardial
Ischemia on the Ergocycle versus the treadmill in patients with coronary heart disease. Am J
Cardiol 2010; 105:633-9.
12. Cardinal H, Bogaty P, Madore F, Boyer L, Joseph L, Brophy JM. Therapeutic Management
in Patients with Renal Failure who Experience an Acute Coronary Syndrome. Clin J Am Soc
Nephrol 2009;5:87-94.
Peter Bogaty MD
Page 19 of 34
13. Bogaty P, Brophy JM. Letter to the Editor in response to Cantor WJ et al. Routine Early
Angioplasty after Fibrinolysis for Acute Myocardial Infarction. N Eng J Med 2009;361:1508.
14. Bogaty P. Duration of Symptoms Is Not Always the Key Modulator of the Choice of
Reperfusion for ST-Elevation Myocardial Infarction. Circulation 2009;119:1304-10.
15. Bogaty P. Response to Armstrong P et al. Duration of Symptoms Is the Key Modulator of the
Choice of Reperfusion for Myocardial Infarction. Circulation 2009;119:1303.
16. Ferland A, Brassard P, Lemieux S, Bergeron J, Bogaty P, Bertrand F, Simard S, Poirier P.
Impact of High-fat/low-carbohydrate, High-, Low-glycaemic Index or low-caloric Meals on
Glucoregulation during Aerobic Exercise in Type 2 Diabetes. Diabet Med 2009;26:589-95.
17. Dagenais GR, St-Pierre A, Gilbert P, Lamarche B, Després JP, Bernard PM, Bogaty P.
Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular
disease. CMAJ 2009;180:40-7.
18. Bogaty P. Little predictive value in measuring CRP levels in ACS patients, new study
suggests. 9 Juin 2008 http://www.theheart.org/article/873105.do Heart Org 2008
19. Rodés-Cabau J, Noël M, Marrero A, Rivest D, Mackey A, Houde C, Bédard E, Larose E,
Verreault S, Peticlerc M, Pibarot P, Bogaty P, Bertrand OF. Atherosclerotic Burden findings
in young cryptogenic stroke patiens with and without foramen ovale. Stroke 2008;40:419-25.
Epub 2008 Dec 18.
20.
Rodés-Cabau J, Deblois J, Bertrand OF, Mohammadi S, Courtis J, Larose E, Dagenais F,
Déry JP, Mathieu P, Rousseau M, Barbeau G, Baillot R, Gleeton O, Perron J, Nguyen CM,
Roy L, Doyle D, De Larochellière R, Bogaty P, Voisine P. Nonrandomized comparison of
coronary artery bypass surgery and percutaneous coronary intervention for the treatment of
unprotected left main coronary artery disease in octogenarians. Circulation 2008;118:23269. Epub 2008 Nov 24.
21. Bogaty P, Simard S, Dagenais GR, Brophy JM. Acute Coronary Syndromes: “To CRP or not
to CRP?" J Am Coll Cardiol 2008;52:1500; author reply 1500-1.
22. Bogaty P, Boyer L, Simard S, Dauwe F, Dupuis R, Verret B, Huynh T, Roux R, d'Astous M,
Bertrand F, Dagenais GR, Brophy J. Clinical utility of C-reactive protein measured at
admission, hospital discharge or one month later to predict outcome in patients with acute
coronary disease: The RISCA Study. J Am Coll Cardiol 2008;51:2339-46.
23. Bogaty P, Poirier P, Boyer L, Simard S, Morin J, Dagenais GR. Effects of Exogenous
Metabolic Substrate Modulation on Exercise-Induced Myocardial Ischemia. Am Heart J
2008;156:790-796. Epub 2008 Aug 9.766
24. Bogaty P , Brophy JM. Letter to the editor in response to Citywide Protocol for Primary PCI
in ST-Segment Elevation Myocardial Infarction, Le May et al. N Eng J Med 2008;358:1751.
25. Bogaty P, Noël M. Poirier P, Dagenais R. Can prolonged exercise-induced myocardial
ischaemia be innocuous? reply. Eur Heart J. 2008;29:139-40.
26. Bogaty P, Boothroyd L, Lambert L, Lance JM, Paquette D. Enjeux organisationnels
préhospitaliers, intra et interhospitaliers et économiques pour la prise en charge avec
l'infarctus aigu du myocarde avec élévation du segment ST (IAMEST). Agence d'évaluations
des technologies et des modes d'intervention en santé 2007.
http://www.aetmis.gouv.qc.ca/site/34.1064.0.0.1.0.phtml
Peter Bogaty MD
Page 20 of 34
27. Lambert L, Bogaty P, Brophy J, Boothroyd L. La pratique d'interventions coronariennes
percutanées dans les hôpitaux sans service de chirurgie cardiaque sur place: revue des
lignes directrices et analyse des donnée québecoises de 1999-2004. Agence d'évaluations
des technologies et des modes d'intervention en santé 2007.
http://www.aetmis.gouv.qc.ca/site/phpwcms_filestorage/c50a9b653ab55beeda8d2f11a0128
5c6.pdf
28. Bogaty P, Noël M, Poirier P, Dagenais GR. Can prolonged exercise-induced myocardial
ischaemia be innocuous? Author reply. Eur Heart J 2007;29:139-40.
29. Dagenais G, Philippon F, Després JP, Dumesnil JG, Cartier P, Bogaty P, Lemieux M,
Moisan A. The Quebec Heart Institute: 50 years of excellence in cardiology. Can J Cardiol
2007;23:Suppl B:5B-8B.
30. Brassard P, Legault S, Garneau C, Bogaty P, Dumesnil JG, Poirier P. Normalization of
diastolic dysfunction in type 2 diabetics after exercise training. Med Sci Sports Exerc
2007;39:1896-901.
31. Noël M, Jobin J, Marcoux A, Poirier P, Dagenais GR, Bogaty P. Can Prolonged ExerciseInduced Myocardial Ischemia Be Innocuous? Eur Heart J ;28:1559-65.
32. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low flow, low gradient severe
aortic stenosis despite preserved ejection fraction reflects more severe disease and poorer
prognosis: implications for diagnosis and treatment. Circulation 2007;115:2856-64.
33. Noël M, Jobin J, Poirier P, Dagenais GR, Bogaty P. Effect of a ramp versus standard Bruce
exercise test protocol on exercise-induces myocardial ischemia. Am J Cardiol 2007;99:9214.
34. Beanlands RS, Chow BJ, Dick A, Friedrich MG, Gulenchyn KY, Kiess M, Leong-Poi H,
Miller RM, Nichol G, Freeman, Bogaty P, Honos G, Hudon G. Wisenberg G, Van Berkom J,
Williams K, Yoshinaga K, Graham ; on behalf of the Canadian Cardiovascular Society, the
Canadian Association of Radiologist, the Canadian association of Nuclear Medicine, The
Canadian Nuclear Cardiology Society and the Canadian Society of Cardiac Magnetic
Resonance. CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced
noninvasive cardiac imaging using positron emission tomography, magnetic resonance
imaging and multidetector computed tomographic angiography in the diagnosis and
evaluation of ischemic heart disease--executive summary. Can J Cardiol2007;23:107-119.
35. Bogaty P, Brophy JM. Acute ischemic heart disease and interventional cardiology: A time for
a pause. BMC Medicine 2006 ;4 :25.
36. Brassard P, Ferland A, Bogaty P, Desmeules M, Jobin J and Poirier P: Influence of glycemic
control on pulmonary function and heart rate in response to exercise in subjects with type 2
diabetes mellitus Metabolism 2006 ;55:1532-37.
37. Méthot J, Hamelin BA, Arsenault M, Bogaty P, Plante S and Poirier P: The ACE-DD
genotype is associated with endothelial dysfunction in postmenopausal women. Menopause
2006;13:959-66.
38. Bourgault C, Bergeron S, Bogaty P, Poirier P. A most unusual acute coronary syndrome.
Can J Cardiol 2006;22:1-4.
39. Méthot J, Hamelin BA, Bogaty P, Arsenault M, Plante S, Poirier P. ACE-DD genotype is
associated with the occurrence of acute coronary syndrome in postmenopausal women. Int J
Cardiol 2005;105:308-14.
40. Armstrong PW, Bogaty P, Buller CE, O’neill BJ. Guidelines for STEMI. CMAJ
2005;172:1426.
Peter Bogaty MD
Page 21 of 34
41. Bogaty P, Brophy JM. Numbers needed to treat (needlessly?). Lancet 2005;365: 1307-08.
42. Bogaty P, Brophy J. GRACIA : Implications for clinical practice. Lancet 2005;365:381.
43. Bogaty P, Brophy J, Boyer L, Simard S, Bertrand F, Dagenais GR. Fluctuating inflammatory
markers in patients with stable ischemic heart disease. Arch Int Med 2005 ;165 :221-226.
44. Methot J, Hamelin B, Bogaty P, Arsenault M, Plante S, Poirier P. Does hormonal status
influence the clinical presentation of acute coronary syndromes in women? J Womens
Health 2004;13:695-702.
45. Bogaty P, Buller CE, Dorian P, O’Neill BJ, Armstrong PW. Reperfusion in acute ST elevation
myocardial infarction : Application of new ST-elevation myocardial infarction (STEMI)
guidelines. CMAJ 2004 ;171 :1039-1041.
46. Dorian P, Bogaty P, Buller CE, O ‘Neill BJ, Armstrong PW. Disturbances of cardiac rhythm
after ST-elevation myocardial infarction : Application of new ST-elevation myocardial
infarction (STEMI) guidelines. CMAJ 2004 ;171 :1042-44.
47. Brophy JM, Bogaty P. Primary angioplasty and thrombolysis are both reasonable options in
acute myocardial infarction. Ann Int Med 2004;141:292-297.
48. Bogaty P, Brophy J, Boyer L, Simard S, Bertrand F, Noel M, Dagenais GR. Impact of
prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in
patients with ischemic heart disease and raised C-reactive protein: a randomized placebocontrolled study. Circulation 2004;110:934-939.
49. Armstrong P, Bogaty P, Buller C, Dorian P, O'Neill B. The 2004 ACC/AHA Guidelines: A
Perspective and Adaptation for Canada by the Canadian Cardiovascular Society Working
Group. Can J Cardiol 2004;20:1075-1079.
50. Bogaty P, Brophy J. Primary angioplasty or thrombolysis? A topical parable. BMJ
2004;328:1257-1258.
51. Fitchett D, Rockwood K, Chan BT, Schultz S, Bogaty P, Gillis A, Arnold M, Miller F, Graham
MM, Ghali WA, Cartier R. Chow CM, Grymonpre R, Ogilvie R, Rochon P, Niznick J, Grover
S, Kavanah T, Triscott J, Dafoe W, McCartney N, Rodney P, Howlett J, Chockalingam A,
Dagenais G, Dalziel W, Fodor G, Goodman S, Kerr C, Power B. Murphy K. Canadian
Cardiovascular Society Consensus Conference 2002: Management of heart disease in the
elderly patient. Can J Cardiol 2004;20(suppl A):7A-16A.
52. Bogaty P, Dagenais GR, Poirier P, Boyer L, Auclair L, Pépin G, Jobin J, Arsenault M. Effect
of Atorvastatin on exercise-induced myocardial ischemia in patients with stable angina
pectoris. Am J Cardiol 2003;92:1192-1195.
53. Bogaty P, Brophy J. Increasing burden of treatment in the acute coronary syndromes : Is it
justified? Lancet 2003;361:1813-1816.
54. Dagenais GR, Auger P, Bogaty P, Gerstein H, Lonn E, Yi Q, Yusuf S; HOPE Study
Investigators.Increased occurrence of diabetes in people with ischemic cardiovascular
disease and general and abdominal obesity. Can J Cardiol. 2003;19:1387-1391.
55. Bogaty P, Poirier P, Dagenais GR, Boyer L, Jobin J. What induces warm-up ischemia /
Angina Phenomenon: exercise or myocardial ischemia? Circulation 2003;107:1858-1863.
56. Hamelin BA, Methot J, Arsenault M, Pilote S, Poirier P, Plante S, Bogaty P. Influence of the
menstrual cycle on the timing of acute coronary events in young women with coronary artery
disease. Am J Med 2003;114:599-602.
Peter Bogaty MD
Page 22 of 34
57. Poirier P, Bogaty P, Philippon F, Garneau C, Fortin C, Dumesnil JG. Preclinical diabetic
cardiomyopathy : Relation of left ventricular diastolic dysfunction to cardiac automatic
neuropathy in uncomplicated well-controlled men with type 2 diabetes. Metabolism
2003;52:1056-1061.
58. Morin J, Bogaty PM, Roy L, Poirier P. Trauma-induced occlusion of the left anterior
descending artery following a snowmobile accident in a man without prior coronary artery
disease. Can J Cardiol 2003;5:565-568.
59. Bogaty P, Boyer L, Rousseau L, Arsenault M. Is anteroseptal myocardial infarction an
appropriate term? Am J Med 2002;113:37-41.
60. Bogaty P, Muré P, Dumesnil JG. New Insights into Diastolic Dysfunction as the Cause of
Acute Left-Sided Heart Failure Associated With Systemic Hypertension and/or Coronary
Artery Disease. Am J Cardiol 2002;89:341-345.
61. Cantin B, Despres JP, Lamarche B, Moorjani S, Lupien PJ, Bogaty P, Bergeron J, Dagenais
GR. Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in
men (The Quebec Cardiovascular Study). Am J Cardiol 2002;89:662-666.
62. Bergeron S, Demers C, Bogaty P, Poirier P. The endocarditis that was not: an unsual case
of heparin-induced thrombocytopenia with unusual complications. Can J Cardiol
2001;17:1180-1182.
63. Huynh T, Théroux P, Bogaty P, Nasmith J, Solymoss S. Aspirin, warfarin or the combination
for the secondary prevention of coronary events in patients with acute coronary syndromes
and prior coronary artery bypass surgery. Circulation 2001;103:3069-3074.
64. Bogaty P, Poirier P, Simard S, Solymoss S, Boyer L, Dagenais GR. Biological profiles in
subjects with recurrent acute coronary events compared to longstanding stable angina
Circulation 2001;103:3062-3068.
65. Lemieux I, Pascot A, Prud'homme D, Alméras N, Bogaty P, Nadeau A, Bergeron J, Després,
J-P. Elevated C-reactive protein: another component of the atherothrombotic profile of
abdominal obesity. Arterioscler Thromb Vasc Biol 2001;21:961-967.
66. Bogaty P. Myocardial Infarction After Dog Bite. Circulation 2001;103:e95-a.
67. Porier P, Bogaty P, Garneau C, Marois L, Dumesnil J-G. Diastolic dysfunction in
normotensive men with well-controlled type 2 diabetes. Diabetes Care 2001;24:5-10.
68. Bogaty P, Dumont S, O'Hara GE, Boyer L, Auclair L, Jobin J, Boudreault JR. Randomized
trial of a non-invasive strategy to reduce hospital stay for patients with low-risk myocardial
infarction. J Am Coll Cardiol 2001;37:1289-1296.
69. Bogaty P, Kingma J, Guimond J, Poirier P, Boyer L, Charbonneau L, Dagenais GR.
Myocardial perfusion imaging findings and the role of adenosine in the warm-up angina
phenomenon. J Am Coll Cardiol 2001;37:463-469.
70. Kingma JG Jr, Plante S, Bogaty P . Platelet GPIIb/IIIa blockade reduces infarct size in a
canine model of ischemia-reperfusion. J Am Coll Cardiol 2000;36:2317-2324.
71. Poirier P, Garneau C, Bogaty P, Nadeau A, Marois L, Brochu C, Gingras C, Fortin C, Jobin
J, Dumsenil J-G. Impact of left ventricular diastolic dysfunction on maximal treadmill
performance in normotensive subjects with well-controlled type 2 diabetes mellitus. Am J
Cardiol 2000;85:473-477.
72. Bogaty P, Dagenais GR. Revascularization after myocardial infarction. Circulation
1999;99:1272-1273.
Peter Bogaty MD
Page 23 of 34
73. Bogaty P, Kingma JG, Robitaille N-M, Plante S, Simard S, Charbonneau L, Dumesnil JG.
Attenuation of myocardial ischemia with repeated exercise in subjects with chronic stable
angina: relation to myocardial contractility, intensity of exercise, and the ATP-sensitive
potassium channel. J Am Coll Cardiol 1998;32:1665-1671.
74. Bogaty P, Robitaille N-M, Solymoss S, Boyer L, Auger D, Labbé L, Simard S, Rail J, Genest
Jr J, Turgeon J. Atherogenic, hemostatic and other potential risk markers in subjects with
previous isolated myocardial infarction compared to longstanding uncomplicated stable
angina. Am Heart J 1998;136:884-893.
75. Tanser P, Baird M, Bogaty P, Bernstein V, Cox J, Cujec B, Finnie K, Langer A, McCans J,
McKelvie R, Miller A, Parker JO, Rose B, Sestier F, Warnica W. Canadian Cardiovascular
Society 1997 Consensus Conference on the Evaluation and Management of Chronic
Ischemic Heart Disease. Can J Cardiol 1998;14 (Suppl C):1C-24C.
76. Brophy JM, Diodati JG, Bogaty P, Théroux P. The delay to thrombolysis: An analysis of
patient and hospital characteristics. CMAJ 1998;158:475-480.
77. Cairns J, Théroux P, Armstrong P, Bogaty P, Kells C, Thompson C, Warnica W. Unstable
angina: report from a Canadian Expert Roundtable. Can J Cardiol 1996;12:1279-92 (also
appears in ACC Current Journal Review July/August 1998 pp 43-8).
78. Miyagashima R, Plante S, Abel JG, Bogaty P. Unstable Angina and non-Q-wave infarction.
Can J Cardiol 1997;13 (suppl D):30D-39D.
79. Bogaty P, Guimond J, Robitaille N-M, Rousseau L, Simard S, Rouleau JR, Dagenais GR. A
reappraisal of exercise electrocardiographic indices of the severity of ischemic heart disease:
angiographic and scintigraphic correlates. J Am Coll Cardiol 1997;29:1497-1504.
80. çKingma JG Jr, Bogaty P. Reperfusion injury: fact, fiction or simply unresolvable? J Thromb
Thrombolysis 1997;4:145-147.
81. Cairns J, Theroux P, Armstrong P, Bogaty P, Kells C, Thompson C, Warnica W. Unstable
Angina—report from a Canadian expert rountable. Can J Cardiol 1996;12:1279-1292.
82. Dagenais GR, Cantin B, Dagenais F, Lupien PJ, Robitaille N-M, Bogaty P. Importance of
outside hospital mortality as a first acute ischemic heart event: The Quebec Cardiovascular
Study. Can J Cardiol 1996;12:914-918.
83. Bogaty P, Hackett D, Davies G, Maseri A. Vasoreactivity at culprit lesions (Letters to the
Editor) Circulation 1995;91:563-564.
84. Bogaty P, Gavrielides S, Mure P, Gaspardone A, Maseri A. The duration and magnitude of
ST segment depression during exercise and recovery: A symmetrical relationship. Am Heart
J 1995;12:666-671.
85. Bogaty P, Hackett D, Davies G, Maseri A. Vasoreactivity of the culprit lesion in unstable
angina. Circulation 1994;90:5-11.
86. Bogaty P, Brecker SJ, White SE, Stevenson RN, El-Tamimi H, Balcon R, Maseri A. A
comparison of coronary angiographic findings at acute and chronic first presentation of
ischemic heart disease. Circulation 1993;87:1938-1946.
87. Tousoulis D, Kaski JC, Bogaty P, Crea F, Gavrielides S, Galassi A, Maseri A. Reactivity of
proximal and distal angiographically normal and stenotic coronary segments in chronic
stable angina. Am J Cardiol 1991; 67:1195-200.
Peter Bogaty MD
Page 24 of 34
88. Dagenais GR, Rouleau JR, Bogaty P. Prognosis for patients with painless strongly positive
exercise ECGs. J Angina Silent Ischemia 1990; 5:4-7.
89. Bogaty P, Dagenais GR, Cantin B, Alain P, Rouleau JR. Prognosis in patients with a
strongly positive exercise electrocardiogram. Am J Cardiol 1989;64:1284-8.
90. Bogaty P, Waters DD. Circadian patterns in coronary disease: the mournefulness of
morning. Can J Cardiol 1988;4:5-11.
MANUSCRIPTS to be submitted To Medical Journals
Boothroyd LJ, Lambert LJ, Sas G, Guertin JR, Ducharme A, Charbonneau E, Carrier M, Cecere
R, Morin JE, Bogaty P. How to support informed decision-making for patients considering longterm mechanical circulatory support: a systematic review of outcomes and perspectives of
recipients and caregivers. In press Circulation: Cardiovascular Quality and Outcomes 2013
Boothroyd LJ, Lambert LJ, Sas G, Guertin JR, Ducharme A, Charbonneau E, Carrier M, Cecere
R, Morin JE, Bogaty P, Should eligibility for heart transplantation be an absolute requirement for
left ventricular assist device (LVAD) use in end-stage heart failure? A systematic review. Can J
Cardiol 2013
Cardinal H, Madore F, Brophy JM, Joseph L, Hebert MJ, Boyer L, Bogaty P. Longitudinal trends
in markers of apoptosis and inflammation after an acute coronary syndrome. 2012
Bogaty P, Dagenais GR, Joseph L, Leblanc A, Boyer L, Brophy JM. Fluctuating Values of CReactive Protein Across Time Intervals: Implications for Risk Stratification. 2012
Published BOOK CHAPTERS
1. Brophy JM, Bogaty P, Hot Topic: Cyclooxygenase-2 inhibition and coronary risk.
Harrisons’online updates http://www.accessmedicine.com 2005 Related To: Chapter 225.
Prevention and Treatment of Atherosclerosis; Chapter 226. Ischemic Heart Disease; Chapter
312. Osteoarthritis.
2. Dagenais GR, Bogaty P. Impacts of ACE inhibitors on diseases of the heart, kidneys, and
brain. In Drug Advances, Jean Gray, ed., REMEDICA Publishing Ltd (London, UK) 2003,
Chapter 5, pp. 113-135.
3. Bogaty P, Waters DD. Circadian patterns in heart disease. Chronopharmacology: Cellular
and Biochemical Interactions, edit. Bjorn Lemmer. Marcel Dekker Inc., New York and Basel
1989. Chapter 22, pp 509-24.
Peter Bogaty MD
Page 25 of 34
ABSTRACTS - - CARDIOLOGY CONVENTIONS
1.
Sas J, Lambert LJ, Boothroyd LJ, Ducharme A, Charbonneau E, Carrier M, Cecere R,
Guertin JR, Morin JE, Bogaty P. What Can The Patient With Chronic End-Stage Heart
Failure Expect Fromm a Long-Term Left Ventricular Assist Device? A Systematic Review
of Current Evidence. Can J Cardiol 2012;28(Suppl):S337-S338.
2.
Bogaty P, Xiao Y, Rinfret S, L’Allier P, Segal E, Maire S, Kouz S, Ross D, Vanasse A,
Nasmith J, Lambert LJ. Clinical Profiles Associated With Timing of Death in Patients With
ST-Elevation Myocardial Infarction: Results of a Province-Wide Field Evaluation. Can J
Cardiol 2012;28(Suppl):S377-S378.
3.
Lambert LJ, Xiao Y, Rinfret S, L’Allier P, Segal E, Maire S, Kouz S, Ross D, Vanasse A,
Nasmith J, Bogaty P. A Comparison of Outcomes of Patients with ST-Elevation Myocardial
Infarction by Type of Hospital and Choice of Treatment: Results of a Quebec-Wide
Systematic Field Evaluation (2008-2009). Can J Cardiol 2012;28(Suppl):S378-S379
4.
Lambert LJ, Xiao Y, Rinfret S, L’Allier P, Maire S, Kouz S, Ross D, Segal E, Vanasse A,
Nasmith J, Bogaty P. Short Term Mortality in ST-Elevation Myocardial Infarction (STEMI)
Patients treated With Primary Angioplasty (PPCI): A Province-Wide. Systemactic Field
Evalution . Can J Cardiol 2012;28(Suppl):S379-S380
5.
Lambert LJ, Brown K, Brophy JM, Nasmith J, Segal E, Rodés-Cabau J, Carroll C, Giguère
M, Bogaty P. Long-term Outcomes Of Patients With ST-Elevation Myocardial Infarction
(STEMI) With And Without Reperfusion Therapy: Results Of A Systematic Province-wide
Field Evaluation In Quebec. Circ Cardiovasc Qual Outcomes 2012;5:A37.
6.
Lambert LJ, Boothroyd LJ, Spaziano M, Guertin JR, Rodés-Cabau J, Noiseux N, Nguyen
M, Dumont E, Carrier M, de Varennes B, Ibrahim R, Martucci G, Xiao Y, Morin JE, Bogaty
P. Where Clinical Practice, Emerging Medical Technology, And Evaluation Intersect In A
Healthcare System Based On Equal Access: The Example Of Transcatheter Aortic Valve
Replacement. Circ Cardiovasc Qual Outcomes 2012;5:A261.
7.
Lambert LJ, Xiao Y, Kouz S, Rinfret S, Ross D, Segal E, L'Allier Philippe L, Maire S,
Vanasse A, Carroll C, Beauchamp C, Giguère M, Bogaty P. The Importance Of Assessing
Inter-regional Systems Of Healthcare In Patients With ST-Elevation Myocardial Infarction
(STEMI): Examples From A Systematic Field Evaluation. Circ Cardiovasc Qual Outcomes
2012;5:A195
8.
Bogaty P, Xiao Y, Nasmith J, Segal E, Kouz S, Rinfret S, L’Allier P, Ross d, Vanasse A
Maire S, Lambert L. Under the Radar: Deaths From ST-Elevation Myocardial Infarction
That Do Not Appear in Registries. Circulation 2011;124(Suppl A):1280.
9.
Lambert L, Sas G, Boothroyd LJ, Guertin JR, Carrier M, Cecere R, Charbonneau E,
Ducharme A, Bogaty P. A New Model For Evalating Emerging Technologies: The Example
Of Ventricular Assist Devices. CCS 2011; Can J Cardiol 2011;27(Suppl):S257.
10.
Lambert L, Xiao Y, Boothroyd L, Segal E, Ross D, Maire S, Kouz S, L’Allier P, Rinfret S,
Vanasse A, Bogaty P. The Introduction of Prehospital ECGs Into a Provincial System of
ST-Elevation Myocardial Infarction (STEMI) Care: Impact on Treatment Delays And the
Process of Care. CCS 2011; Can J Cardiol 2011;27(Suppl):S62-S63.
11.
Lambert L, Ross D, Segal E, Maire S, L’Allier P, Vanasse A, Rinfret S, Kouz S, Bogaty P.
Centers that perform primary percutaneous coronary intervention without on-site cardiac
surgery in a system of care of patients with ST-elevation myocardial infarction: Results
from a systematic province-wide field evaluation Can J Cardiol 2011;27(Suppl):S61-S62.
Peter Bogaty MD
Page 26 of 34
12.
Lambert L, Brown K, Brophy JM, Roges-Cabau J, Segal E, Bogaty P. Long-Term
outcomes of Patients With ST-Elevation Myocardial Infarction With And Without
ReperfusionTherapy: Results from a systematic, province-wide field evaluation in Quebec.
Can J Cardiol 2011;27(Suppl):S61.
13.
Lambert L, Chakor H, Ross D, Segal E, Xiao Y, Vanasse A, Maire S, Kouz S, Rinfret S,
L'Allier P, Bogaty P. Teasing Out Why Reperfusion Therapy Was Not Given to a
Substantial Number of Patients With ST-Elevation Myocardial Infarction (STEMI): A
Classification Tool Developed From a Province-Wide Systematic Field Evaluation. Can J
Cardiol 2011;27(Suppl):S145.
14.
Lambert L, Ross D, Segal E, Maire S, L’Allier P, Vanasse a, Rinfret S, Kouz S, Chakor H,
Bogaty P. Patients With ST-Elevation Myocardial Infarction Sent For Primary Percutaneous
Coronary Intervention And Who do Not Receive it: Results From a Systematic ProvinceWide Evaluation. Can J Cardiol 2011;27(Suppl):S63.
15.
Lambert L, Boothroyd LJ, Xiao Y, Caroll C, Giguere M, Bogaty P. Characteristics of
Practice of Primary Angioplasty Across 13 PCI Centers in Quebec (2008-2009): A
Province-Wide Systematic Field Evaluation. Can J Cardiol 2011;27(Suppl):S62.
16.
Bogaty P, Xiao Y, Nasmith J, Segal E, Kouz S, Rinfret S, L'Allier P, Ross D, Vanasse A,
Maire S, Lambert L. Under the Radar: Deaths From ST-Elevation Myocardial Infarction
That Do Not Appear in Registries. Can J Cardiol 2011;27(Suppl):S63.
17.
Lambert L, Xiao Y, L’Allier P, Kouz S, Rinfret S, Ross D, Segal E, Maire S, Vanasse A,
Bogaty P. Characteristics of practice of primary angioplasty in the province of Quebec,
Canada (2008-2009): A systematic field evaluation. Circ Cardiovasc Qual Outcomes
2011;4:AP102.
18.
Lambert L, Xiao Y, Boothroyd L, Segal E, Ross D, Maire S, Kouz S, L’Allier P, Rinfret S,
Vanasse A, Bogaty P. The introduction of prehospital ECGs into a provincial system of STelevation myocardial infarction (STEMI) care : Impact on treatment delays and the process
of care. Circ Cardiovasc Qual Outcomes 2011;4:AP123
19.
Brown KA, Lambert LJ, Nasmith J, Segal E, Carroll C, Giguere M, Bogaty P. Why do some
Patients Not Receive ReperfusionTherapy For ST-Elevation Myocardial Infarction
(STEMI)? A Field Evaluation With Expert Core Laboratory Electrocardiographic Analysis.
Circ Cardiovasc Qual Outcomes 2011;4:AP318.
20.
Doucette K, Brophy JM, Boyer L, Simard S, Dagenais GR, Bogaty P. Can recurrent acute
coronary events be predicted by C-reactive protein measurements in the previous six
weeks? Can J Cardiol 2010;26 (Suppl D):121D.
21.
Brown KA, David K, Lambert LJ, Bogaty P. Reliability of the assessment of patient
comorbidities using Quebec’s medico-administrative data. Can J Cardiol 2010;26 (Suppl
D):29D.
22.
Lambert LJ, Poliquin S, Brown KA, Moutquin J, Carrier M, Langlois Y, Mathieu P,
Dendukuri N, Morin JE, Guertin J, Bogaty P. A coronary artery bypass graft surgery
(CABG) evaluation project : by, for, and with cardiac surgeons. Can J Cardiol 2010;26
(Suppl D):29D.
23.
Brown KA, David K, Lambert LJ, Bogaty P. Can Quebec’s hospital inpatient and day
surgery database (Med-Écho) be used to count Percutaneous Coronary Interventions (PCI)
In Quebec ? Can J Cardiol 2010;26 (Suppl D):28D.
Peter Bogaty MD
Page 27 of 34
24.
Lambert LJ, Brown KA, Carroll C, Segal E, Ross D, Lefrançois D, Smith W, Maire S,
Giguère M, Guertin JR, Boothroyd L, Bogaty P. Systems of care for ST-elevation
myocardial infarction (STEMI) : An evaluation model for the province of Quebec. Can J
Cardiol 2010;26 (Suppl D):128D.
25.
Lambert L, Carroll-Bilodeau C, Giguere M, Morin J, Boothroyd L, Bogaty P. Portrait of
Treatment of Myocardial Infarction with ST-Elevation (STEMI) in PCI-Capable Hospitals in
Quebec, Canada: Mode of Reperfusion and Treatment Delays. Circ Cardiovasc Qual
Outcomes 2009;2:e40.
26.
Cardinal H, Brophy JM, Bogaty P, Joseph L, Hébert M, Boyer L, Madore F. sFAS improves
diagnostic accuracy for acute coronary syndromes in patients presenting with chest pain.
Can J Cardiol 2008;24(Suppl SE):809
27.
Thrombolytic Treatment for Myocardial Infarction withST-Elevation (STEMI) in Quebec,
Canada: A Province-Wide Field Evaluation. Circ Cardiovasc Qual Outcomes 2009;2:e9
28.
Lambert L, Simard S, Carroll-Bilodeau C, Giguere M, Morin J, Boothroyd L, Bogaty P.
Reliability of Process Measures of Care of Patients Presenting with ST-Elevation
Myocardial Infarction (STEMI) Abstracted by Hospital Health Record Librarians: Results of
a Field Evaluation in Quebec, Canada. Circ Cardiovasc Qual Outcomes 2009;2:e40.
29.
Delays for Transfers of Patients With ST-Elevation Myocardial Infarction (STEMI) for
Primary PCI in Quebec, Canada : A Step-by-Step Analysis. Circ Cardiovasc Qual
Outcomes 2009;2:e40
30.
Lambert L, Carroll-Bilodeau C, Giguere M, Morin J, Boothroyd L, Nasmith J, Bogaty P.
Identification of Appropriate Patients for Inclusion in Process Measures of Care of
Myocardial Infarction with ST-Elevation (STEMI). Circ Cardiovasc Qual Outcomes
2009;2:e9.
31.
St-Germain C, Hanley J, Bogaty P, Boyer L, Engert JC, Brophy JM. Genetic Polymorphism
and the cardiovascular risk of Cyclooxygenase-2 inhibitors. J Am Coll Cardiol
2008;51(Suppl1):A195.
32.
Bogaty P, Boyer L, Simard S, Dauwe F, Dupuis R, Verret B, Huynh T, Bertrand F,
Dagenais GR, Brophy JM. Does the pattern of serial values of C-Reactive Protein predict
outcome in patiens with acute coronary disease? The RISCA Study. J Am Coll Cardiol
2008;51(Suppl 1):A219.
33.
Cardinal H, Madore F, Brophy J, Bogaty P. The Therapeutic Impact of Renal Failure in
Patients who Experience an Acute Coronary Syndrome: Are We Undertreating a HigherRisk Subset? J Am Soc Nephrol 2007, vol 18, p.584-A.
34.
Lambert LJ , Bogaty P, Baillot R, Morin JE, Cartier R, Brophy JM. Coronary artery bypass
surgery and associated mortality in the Quebec elderly, 1993-2004. Can J Cardiol
2007;23(Suppl C):492.
35.
Lambert LJ, JM Brophy, JE Morin, P Bogaty. Percutaneous coronary intervention and
associated mortality in the Quebec elderly, 1993-2004. Can J Cardiol 2007;23(Suppl
C):115.
36.
Noel M, Marcoux A, Boyer L, Simard S, Bertrand F, Bogaty P. Transient increase in blood
inflammatory makers following intense exercise in healthy elderly men. Can J Cardiol
2007;23(Suppl C):795.
Peter Bogaty MD
Page 28 of 34
37.
Côté J, Bertrand O, Rodes-Cabau J, Bogaty P, Champagne J, Brochu B, Miro S, Barbeau
G, Noël B, Poirier P, Despres J, Larose E. Epicardial fat measured during routine
cardiovascular magnetic resonnance predicts coronary artery disease. Can J Cardiol
2007;23(Suppl C):893.
38.
Larose E, Côté J, Rodes-Cabau J, Bogaty P, Champagne J, Brochu B, Miro S, Noël B,
Poirier P, Bertrand O, Despres J. Epicardial fat measured during routine cardiovascular
magnetic resonnance predicts coronary artery disease. J Cardiovasc Magn Res
2007;9(Suppl 1):443.
39.
Cardinal H, Brophy J, Bogaty P, Brassard N, Madore F. Do Soluble FAS and Endothelial
Apoptotic Microparticles predict recurrent cardiovascular events in patients with an acute
coronary syndrome. Can J Cardiol 2007;23(Suppl C):797.
40.
Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Low flow, low gradient severe aortic
stenosis despite preserved ejection fraction: a paradoxical patter that is associated with
higher LV afterload and increased mortality. Eur Heart J 2007;28(Suppl I):3405.
41.
Garceau P, Noël M, Samson M,, Poirier P, Bogaty P. Impact of altitude-induced
hypoxemia on myocardial function in healthy climbers. Can J Cardiol 2007;23(Suppl
C):149.
42.
Noel M, Cabau JR, Rivest D, Mackey A, Houde C, Cote J, Chetaille P, Delisle G, Bogaty P,
Bertrand OF. The impact of atherosclerotic burden in cryptogenic stroke of young patients
with and without paten foramen ovale. Can J Cardiol 2007;23(Suppl C):364.
43.
àNoel M, Jobin J, Poirier P, Dagenais G, Bogaty P. Less myocardial ischemia on the
ergocycle than on the treadmill: Is it the exercise protocol or the machine. Can J Cardiol
2007;23(Suppl C):913.
44.
Brassard P, Legault S, Garneau C, Bogaty P, JG Dumesnil JG, Poirier P. Aerobic exercise
training reverses diastolic dysfunction uncomplicated well-controlled type 2 diabetes.
Diabetes 2007;56(Suppl 1):277A.
45.
Bogaty P, Dauwe F, Boyer L, Simard S, Dupuis R, Verret B, Huynh T, Roux R, d'Astous
M, Bertrand F, Dagenais GR, Brophy J. Does C-Reactive protein at admission, discharge
or one month have incremental clinical value to predict outcome in patients with acute
coronary disease. J Am Coll Cardiol 2007; 49(Suppl 1):199A.
46.
Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low flow, low gradient severe
prognosis: implications for diagnosis and treatment. Circulation 2006;114(Suppl II):II-714.
47.
Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low flow, low gradient severe
prognosis: implications for diagnosis and treatment. Can J Cardiol 2006;22(Suppl D):218D.
48.
Noël M, Jobin J, Marcoux A, Boyer L, Bogaty P. Does sustained ischemic exercise cause
myocardial damage? Circulation 2005;112 :II-811
49.
Méthot J, Hamelin BA, Arsenault M, Bogaty P, Plante S, Poirier P. ACE-DD genotype is
associated with endothelial dysfunction in postmenopausal women. Circulation
2005;112 :II-202.
50.
Noël M, Jobin J, Poirier P, Dagenais GR, Bogaty P. Does a gradual exercise test ramp
attenuate myocardial ischemia? J Am Coll Cardiol 2005;45(Suppl A):211A-212A .
Peter Bogaty MD
Page 29 of 34
51.
Dagenais GR,Gilbert P, St-Pierre AC, Lamarche B, Després JP, Bogaty P. Long-term
cardiovascular consequences of diabetes among Quebec men, The Quebec
Cardiovascular Study. Can J Cardiol 2005;21(Suppl C):222C.
52.
Dagenais GR,Gilbert P, St-Pierre AC, Lamarche B, Després JP, Bogaty P. Long-term
disastrous impact of tobacco among Quebec men, The Quebec Cardiovascular Study. Can
J Cardiol 2005;21(Suppl C):137C.
53.
Bogaty P, Brophy JM, Noël M et al. Impact of prolonged Cyclooxygenase-2 inhibition on
inflammatory markers and endothelial function in patients with ischemic heart disease and
raised C-reactive protein: A randomized placebo-controlled study. ACC Current Journal
Review 2004 page 13.
54.
Méthot J, Hamelin BA, Arsenault M, Bogaty P, Plante S, Poirier P. ACE-DD genotype is
associated with endothelial dysfunction in postmenopausal women. Can J Cardiol
2005;21:113C.
55.
Méthot J, Hamelin BA, Bogaty P, Arsenault M, Plante S, Poirier P. Does ACE-DD genotype
play a role on the timing acute coronary events during the menstrual cycle in
premenopausal women? Can J Cardiol 2005;21:233C.
56.
Noël M, Jobin J, Poirier P, Dagenais GR, Bogaty P. Does a gradual exercise test (RAMP)
attenuate myocardial ischemia? Clin Invest Med 2005;28; 26.
57.
Méthot J, Hamelin BA, Arsenault M, Bogaty P, Poirier P. Does renin angiotensin system
genotypes is associated with flow-mediated dilatation of the brachial artery in
postmenopausal? Can J Diabetes 2004;28:306.
58.
Noël M, Jobin J, Poirier P, Dagenais GR, Bogaty P. L’ischémie myocardique induite à
l’effort: différence marquée entre l’ergocycle et le tapis roulant? Med Sci 2004;20:21.
59.
Ferland A, Turbide G, Bogaty P, Jobin J, Larivière MM, Poirier P. Type 2 diabetes and
aerobic exercise – Is prior breakfast deleterious? Med Sci Sports Exerc 2004;36:2281.
60.
Pilote B, Bogaty P, Lacourcière Y, Ferland A, Poirier P. Relation entre la tension artérielle
exagérée à l’effort et le monitorage de la tension artérielle chez les diabétiques de type 2.
Med Sci 2003;19 (Suppl 1):16.
61.
Pilote B, Bogaty P, Ferland A, Lacourcière Y, Poirier P. Association between exaggerated
blood pressure response to exercise and cardiac autonomic nervous system modulation in
men with type 2 diabetes free of heart disease. Am J Sports Med 2003;5:182.
62.
Méthot J, Hamelin BA, Bogaty P, Arsenault M, Plante S, Poirier P GR. Difference in the
clinical presentation of acute coronary syndrome between premenopausal and
postmenopausal women. Circulation 2002;106 (Suppl II):II-540.
63.
Méthot J, Hamelin BA, Bogaty P, Aresenault M, Plante S, Poirier P. ACE-DD genotype is
associated with the occurrence of acute Coronary syndrome in postmenopausal women,
Can J Cardiol 2002;19 (Suppl A):248A.
64.
Méthot J, Poirier P, Bogaty P, Arsenault M, Plante S and Hamelin BA. Does renin
angiotensin polymorphisms in postmenopausal women impact the occurrence of acute
coronary syndrome? Can J Cardiol 2002;18 (Suppl B):211B.
65.
Pilote B, Bogaty P, Lacourcière Y, Ferland A, Brochu C, Poirier P. Relationship between
exaggerated blood pressure response to exercise and ambulatory blood pressure in
patients with type 2 diabetes. Can J Cardiol 2002;18 (Suppl B):213B.
Peter Bogaty MD
Page 30 of 34
66.
Bogaty P, Boyer L, Simard S, Bertrand F, Hamelin B, Dagenais GR. P-Selectin as a
marker of acute coronary artery disease risk independent of C-reactive protein. Circulation
2001;104 (Suppl II):II-636.
67.
Bogaty P, Poirier P, Boyer L, Auclair L, Pepin G, Jobin J, Arsenault M. Relation of serial
changes in endothelial function, exercise ischemic parameters, and blood markers in
subjects with stable angina undergoing aggressive lipid-lowering: The Can-ADA endothelial
dysfunction substudy. Circulation 2001;104 (Suppl II):II-446.
68.
Dagenais GR, Auger P, Bogaty P, Bosch J, Gerstein HC, Lonn E, Yi Q, Yusuf S. Impact of
Abdominal Obesity on the Occurrence of Diabetes in Subjects with Ischemic
Cardiovascular Disease. Circulation 2001;104 (Suppl II):II-833.
69.
Bogaty P, Boyer L, Rousseau L, Arsenault M. Is anteroseptal myocardial infarction an
appropriate term? Circulation 2000;102 (Suppl II):II-793-4.
70.
Methot J, Bogaty P, Poirier P, Arsenault M, Pilote S, Plante S, Hamelin BA. The
relationship of the occurrence of acute coronary events in women to the timing of their
menstrual cycle. Circulation 2000;102 (Suppl II):II-613.
71.
Bogaty P, Poirier P, Boyer L, Auclair L, Jobin J. What induces warm-up angina: exercise or
myocardial ischemia? Circulation 2000;102 (Suppl II):II-522.
72.
Bogaty P, Boyer L, Arsenault M. Is the electrocardiographic anteroseptal myocardial
infarction really anteroseptal? Can J Cardiol 2000;16 (Suppl F):157F.
73.
Bogaty P, Leiter L, Murray P, Angus C, on behalf of the Can-ADA Study Investigators. The
Can-ADA Study: Do lipid parameters respond differently to atorvastatin therapy in ischemic
heart disease subjects with and without type 2 diabetes? Can J Cardiol 2000;16 (Suppl
F):234F.
74.
Bogaty P, Poirier P, Boyer L, Auclair L, Jobin J. What induces warm-up angina: exercise or
myocardial ischemia? Can J Cardiol 2000;16 (Suppl F):192F.
75.
Huynh T, Théroux P, Nasmith J, Bogaty P, Solymoss S. Aspirin, warfarin and their
combination in secondary prevention of patients with non-ST elevation coronary
syndromes and a prior coronary artery bypass surgery. Can J Cardiol 2000;16 (Suppl
F):139F.
76.
Baillot P, Bogaty P, Lemieux M, Doyle D, Bauset R, Desaulniers D, Métras J, Perron J,
Raymond G, Cartier P, Brochu H, Simard S. Dissociation between short-term morbidity and
mortality in diabetic women undergoing coronary artery bypass. The First International
Conference on Women, Heart Disease and Stroke. Victoria, BC, May 7-10, 2000. Can J
Cardiol 2000;16 (Suppl B):33B.
77.
Bogaty P, Poirier P, Boyer L, Simard S, Bertrand F, Dagenais GR. Is C-reactive protein a
marker for first and recurrent acute coronary events in very different subsets of stable
ischemic heart disease? J Am Coll Cardiol 2000;35:313A.
78.
Bogaty P, O'Hara GE, Boyer L, Auclair L, Arsenault M, Leblanc MH, Boudreault JR. A
novel non-invasive short hospital stay strategy for patients with low risk myocardial
infarction: six month follow-up. J Am Coll Cardiol 2000;35:347A.
79.
Poirier P, Garneau C, Bogaty P, Fortin C, Marois L, Phillipon F, Dumesnil JG. Preclinical
diabetic cardiomyopathy: association between asymptomatic left ventricular dysfunction
and sub-clinical cardiac autonomic neuropathy in men with type 2 diabetes J Am Coll
Cardiol 2000;35:208A.
Peter Bogaty MD
Page 31 of 34
80.
Méthot J, Bogaty P, Poirier P, Arsenault M, Simard J, Plante S, Robitaille NM and Hamelin
BA: Association of polymorphisms in the renin-angiotensin system with acute coronary
events in women. Pharmacotherapy 2000;20:1271.
81.
Bogaty P, Hamelin B, Charbonneau L, Dion B, Boyer L, Kingma Jr JG. Is adenosine the
mediator of warm-up angina? Circulation 1999;100 (suppl):I-506.
82.
Bogaty P, O'Hara GE, Dion B, Auclair L, Boyer L, Arsenault M, Leblanc MH, Boudreault
JR. A short hospital stay strategy for patients with low risk myocardial infarction: six month
follow-up. Can J Cardiol 1999;15 (Suppl):135D.
83.
Bogaty P, Poirier P, Boyer L, Simard S, Bertrand F, Dagenais GR. Is C-reactive protein a
marker for first and recurrent acute coronary events in stable ischemic heart disease
subjects? Can J Cardiol 1999;15 (Suppl):131D.
84.
Bogaty P, Hamelin B, Charbonneau L, Dion B, Boyer L, Kingma Jr JG. Is Adenosine the
mediator of warm-up angina. Can J Cardiol 1999;15 (Suppl):224D.
85.
Dumont S, Jobin J, Boudreault JR, Dion B, Auclair L, Bélanger J, O'Hara GE, Bogaty P.
Psychological Impact of a Short Stay Strategy for Low Risk Myocardial Infarction Patients.
Can J Cardiol 1999;15 (Suppl):225D.
86.
Bogaty P, Guimond J, Kingma Jr JG, Robitaille N-M, Charbonneau L, Dagenais GR. The
relation of myocardial perfusion findings to the attenuation of myocardial ischemia
observed with repeated exercise. Circulation 1998;98 (suppl):I-708-9.
87.
Bogaty P, O’Hara GE, Dion B, Auclair L, Boyer L, Arsenault M, Lebanc M-H, Augustin C-E,
Boudreault J-R. Short hospital stay for uncomplicated myocardial infarction. Circulation
1998;98 (suppl):I-630-1.
88.
Bogaty P, Turgeon J, Solymoss S, Poirier P, Boyer L, Simard S, Dagenais GR. Biological
profile in subjects with multiple acute coronary events compared to longstanding stable
angina. Circulation 1998;98 (suppl):I-765.
89.
Bogaty P, Guimond J, Kingma Jr JG, Charbonneau L, Robitaille N-M, Dagenais GR.
Attenuation of myocardial ischemia with re-exercise: relation to perfusion findings. Can J
Cardiol 1998;14 (Suppl F):85F.
90.
Bogaty P, O’Hara GE, Dion B, Auclair L, Boyer L, Arsenault M, Augustin E, Boudreault J-R.
Short hospital stay for uncomplicated myocardial infarction. Can J Cardiol 1998;14 (Suppl
F):85F.
91.
Bogaty P, Turgeon J, Solymoss S, Poirier P, Boyer L, Simard S, Dagenais GR. Biological
profile in subjects with multiple acute coronary events compared to longstanding stable
angina. Can J Cardiol 1998 (Suppl F);14:116F.
92.
Kingma JG Jr, Plante S, Bogaty P. Blockade of the platelet glycoprotein IIb/IIIa receptor
reduces infarct size in a canine model of myocardial infarction and reperfusion. J Am Coll
Cardiol 1998; 31 (suppl A):135A.
93.
Hamelin BA, Pham D, Desgagnés V, Rail J, Bogaty P, Morin J, Turgeon J. CYP2D6
ultrarapid metabolism and response to metoprolol. Am Coll Clin Pharm 1997 Annual
Meeting.
94.
Bogaty P, Theroux P, for the FRSQ Quebec Acute Coronary Care Working Group. Who
dies in the hospital with an acute coronary syndrome? A contemporary profile from the
Quebec Acute Coronary Registry. Circulation 1997;96(Suppl):I-261.
Peter Bogaty MD
Page 32 of 34
95.
Bogaty P, Solymoss S, Boyer L, Auger D, Simard S, Rail J, Léveillée J, Turgeon J.
Hemostatic and inflammation profile and angiotensin-converting enzyme (ACE) genotype
in subjects with a history of multiple acute coronary events. Can J Cardiol 1997;13(Suppl
C):107C.
96.
Bogaty P, Theroux P, for the FRSQ Quebec Acute Coronary Care Working Group. A
contemporary profile of who dies in the hospital with an acute coronary syndrome: the
Quebec Acute Coronary Registry. Can J Cardiol 1997;13(Suppl C):131C.
97.
Solymoss S, Bogaty P, Boyer L, Auger D, Lipman M, Kwan J. Decreasing activated protein
C resistance ratio correlates with known risk markers in subjects with acute and chronic
ischemic heart disease. Thromb Haemost 1997;78(Suppl):312.
98.
Bogaty P, Robitaille N-M, Boyer L, Auger D, Solymoss S, Turgeon J. Hemostatic and
inflammatory parameters in subjects with previous unheralded myocardial infarction
compared to longstanding uncomplicated stable angina. The 4th International Conference
on Preventive Cardiology, Montreal, 1997. Can J Cardiol 1997;13 (Suppl B):308B.
99.
Bogaty P, Robitaille N-M, Charbonneau L, Plante S, Kingma J. Does glibenclamide block
the attenuation of myocardial ischemia observed with repeated exercise in subjects with
ischemic heart disease? Diabetes 1997;46 (Suppl 1):256A.
100. Bogaty P, Plante S, Rossignol G, Plante M, Rouleau JR, Kingma JG Jr. Rapid cardiac
pacing in the presence of a flow-limiting coronary stenosis does not precondition
sufficiently to limit infarct size. FASEB 1997;12:279A.
101. Bogaty P, Robitaille N-M, Charbonneau L, Plante S, Kingma JG Jr. Role of ATP-sensitive
potassium channels in exercise-induced ischemic preconditioning. Can J Cardiol
1996;12(Suppl E):139E.
102. Bogaty P, Plante S, Rossignol G, Plante M, Rouleau JR, Kingma JG Jr. Effect of demandinduced myocardial ischemia on infarct size in a novel porcine model. Can J Cardiol
1996;12 (Suppl E):160E.
103. Bogaty P, Robitaille N-M, Plante S, Charbonneau L, Beauchemin J, Kingma JG, Dumesnil
JG. Characterization of exercise-induced ischemic preconditioning and its relation with left
ventricular wall motion. Circulation 1995;92 (Suppl):I-736.
104. Bogaty P, Robitaille N-M, Labbé, L, Boyer L, Harnois J, Auger D, Coulombe D, Turgeon J.
Genotype distribution of the angiotensin-converting enzyme insertion/deletion
polymorphism (I/D) in unheralded myocardial infarction and uncomplicated chronic stable
angina. Can J Cardiol 1995;11 (Suppl E):75E.
105. Murè P, Bogaty P, Dumesnil JG. Immediate echocardiography in acute left heart failure:
implications regarding pathogenetic mechanisms. Can J Cardiol 1995;11 (Suppl E):74E.
106. Marceau D, Duchesneau K, Bogaty P. Risks of the totally implanted central venous
catheter in cancer patients: relation to tumour type. Support Care Cancer 1995;3:372.
107. Bogaty P, Brecker SJ, White SE, Stevenson RN, El-Tamimi H, Balcon R, Maseri A. A
comparison of coronary angiographic findings at acute and chronic first presentation of
ischemic heart disease. ACC Curr J Rev 1994;3:9-10.
108. Robitaille NM, Bogaty P, Asselin MJ, Genest M, Labbé L, Lefez C, Turgeon J. Genotype
distribution of the angiotensin converting enzyme insertion/deletion (I/D) polymorphism
differs among young cardiac and young healthy Canadian subjects. Circulation 1994;90
(Suppl):I-110.
Peter Bogaty MD
Page 33 of 34
109. Bogaty P, Guimond J, Rousseau L, Robitaille N-M, Rouleau JR.Angiographic and
scintigraphic correlates of early positivity, ischemic threshold and recovery time in exercise
testing in patients with coronary artery disease. Circulation 1994;90 (Suppl):I-329.
110. Robitaille NM, Bogaty P, Asselin MJ, Genest M, Labbé L, Lefez C, Turgeon J. Genotype
distribution of the angiotensin converting enzyme insertion/deletion (I/D) polymorphism
differs among young cardiac and young healthy subjects. Can J Cardiol 1994;10 (Suppl
C):73C.
111. Bogaty P, Guimond J, Rousseau L, Robitaille NM, Rouleau JR. Does an early positive
exercise test or a prolonged recovery time signify more severe ischemic heart disease ?
Can J Cardiol 1994;10 (Suppl C):102C.
112. Marceau D, Bogaty P. The role of the media and public opinion in transforming hospital
policies regarding terminal care. Support Care Cancer 1994;2.
113. Bogaty P, Guimond J, Rousseau L, Rouleau JR. Does more ST segment depression on
the 12 lead exercise electrocardiogram signify more severe ischemic heart disease?
Circulation 1993;88 (Suppl):I-22.
114. Bogaty P, Davies G, Hackett D, Crake T, Kooner J, Haider AW, Maseri A. Culprit lesion
and downstream vasoreactivity in unstable angina. Circulation 1993;88 (Suppl):I-609.
115. Bogaty P, Kaski JC, Gavrielides S, Tousoulis D, Rouleau J, Maseri A. Recovery time of ST
segment depression correlates with both magnitude of depression at peak exercise and
rate-pressure product during recovery. J Am Coll Cardiol 1992;19 (Suppl):96A.
116. Athanassopoulos G, Joshi J, Marsonis A, Bogaty P, Oakley CM, Nihoyannopoulos P.
Significance of delayed recovery following digital exercise echocardiography and
temporally related ECG changes. Eur Heart J 1991;12 (suppl):399.
117. Galassi A, Kaski JC, Tousoulis D, Bogaty P, Gavrielides S, Crea F, Maseri A. Patterns of
heart rate during exercise testing and ambulatory electrocardiographic monitoring in
patients with Syndrome X. Eur Heart J 1991;12 (suppl):121.
118. Bogaty P, Kaski JC, Gavrielides S, Tousoulis D, Maseri A. Recovery time of ST segment
depression is related to magnitude of depression at peak exercise. Eur Heart J 1991;12
(suppl):329.
119. Bogaty P, Brecker SJ, White SE, El-Tamimi H, Stevenson RN, Balcon R, Maseri A. The
extent of coronary atherosclerosis is very different in unheralded acute myocardial
infarction compared to uncomplicated chronic stable angina. Br Heart J 1991;66:57.
120. Bogaty P, Brecker SJ, White SE, El-Tamimi H, Stevenson RN, Balcon R, Maseri A.
Different coronary angiographic findings in unheralded acute myocardial infarction and
uncomplicated chronic stable angina. J Am Coll Cardiol 1991;17 (suppl A):254A.
121. Tousoulis D, Kaski JC, Crea F, Gavrielides S, Galassi A, Bogaty P, Maseri A. Reactivity of
proximal and distal angiographically normal and stenotic coronary segments in chronic
stable angina. Eur Heart J 1990;11 (suppl):146.
122. Dagenais GR, Bogaty P, Cantin B, Rouleau JR, Dumesnil JG. Does the workload achieved
predict coronary heart events in patients with painless strongly positive exercise test ? Eur
Heart J 1988;9 (Suppl I): 345.
123. Bogaty P, Dagenais GR, Cantin B, Rouleau JR. Does the exercise test predict acute
ischemic cardiac morbid events in patients with strongly positive exercise
electrocardiogram? Circulation 1988;78 (Suppl II):108.
Peter Bogaty MD
Page 34 of 34

CV - Clinique de Cardiologie Montréal

Transcription

Documents pareils

Dublin - DooDooTravel

Chypre Baboo familles été 2010

Noël et Réveillon Spécial à Antalya KW 42.3

BIEN-ÊTRE - KENDROS.com

comite de redaction - Journal Africain d`Imagerie Médicale

Thaïlande - DooDooTravel

prix safaga - lotus bay - ete 2015

Intérêt de la TEP au 18FDG dans l`exploration des tumeurs

SPECIAL IZMIR KW 13.4